The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) have added four medicines to those which must not be parallel exported from the UK. The restriction on the following four lines were introduced from 00:00am 6 November 2019:
- Measles, mumps and rubella vaccine
- Pneumococcal polysaccharide vaccine
The list, will continue to be reviewed on an ongoing basis, to include any product that meets the following criteria:
- the medicine is required to meet the needs of UK patients;
- the medicine is either being parallel exported or is at threat of being parallel exported; and
- the export of that medicine is either contributing to, or may contribute to, a shortage of that medicine in the UK.
The list currently includes products such as adrenaline auto-injectors, estradiol, hepatitis B (rDNA) suspension for injection, levonorgestrel and progesterone.